|
|
|
Volumn 35, Issue 35, 2005, Pages 18-19
|
|
Cashing in on royalties. Sloan-Kettering reaps 142 million dollars in deal.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER CENTER;
COMMERCIAL PHENOMENA;
ECONOMICS;
FINANCIAL MANAGEMENT;
HUMAN;
METHODOLOGY;
ORGANIZATION;
PATENT;
RESEARCH;
TEACHING HOSPITAL;
UNITED STATES;
ACADEMIES AND INSTITUTES;
ANTINEOPLASTIC AGENTS;
CANCER CARE FACILITIES;
CAPITAL FINANCING;
COMMERCE;
HOSPITALS, TEACHING;
HUMANS;
INTELLECTUAL PROPERTY;
NEW YORK CITY;
RESEARCH;
|
|
EID: 26044437528
PISSN: 01607480
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
